HomeNewsGlobal Pharma

Aptar Pharma Acquires Device Technology Assets of SipNose

Aptar Pharma Acquires Device Technology Assets of SipNose

Aptar Pharma has recently acquired all device technology assets from the proprietary portfolio of SipNose Nasal Delivery Systems, a company focused on intranasal delivery platforms for local, systemic and central nervous system indications.

SipNose offers a variety of devices that are designed and adapted to fit a wide range of therapies and offer the opportunity to precisely target areas of the nasal cavity to enable enhanced systemic, local, or even direct-to-brain delivery.

SipNose’s expanded innovative delivery systems, which include liquid and dry powder intranasal delivery, will further strengthen Aptar Pharma’s nose-to-brain pathway expertise and fuel additional development and new scientific research.

Acquiring SipNose’s assets will expand Aptar Pharma’s patent product portfolio and support new product development to further supplement intranasal delivery applications and R&D innovation platforms.

Reenal Gandhi, Business Development Director, Aptar Pharma, commented, “SipNose is focused on development and innovation in intranasal drug delivery. Integrating these assets into our portfolio underlines Aptar Pharma’s continued expansion into the nasal drug delivery space.”

“Our nasal systems’ proven capabilities have brought added value to our customers and further convenience for patients worldwide for over 30 years,” added Alex Theodorakis, President Aptar Pharma Prescription.

“As the nasal market looks to develop new drugs to address unmet patient needs, this transaction will enhance Aptar’s portfolio of nasal drug delivery systems with a focus on CNS diseases,” Theodorakis added.

More news about: global pharma | Published by Aishwarya | October - 10 - 2024 | 102

Last news about this category


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members